Centre for Reproductive Medicine, Ziekenhuis University, Brussel, Belgium.
Research title: Among ICSI patients who undergo antagonist protocols with recombinant FSH, what is the influence on the gene expression profile of the endometrium when recombinant FSH is replaced by 200 IU of hCG in the late follicular phase?
Dr Christophe Blockeel, the principal applicant awarded the prize of 50,000 Euros, is a Fellow in Reproductive Medicine and Clinical Tutor at the Centre for Reproductive Medicine, UZ Brussels, Belgium. Since its creation in 1983, the Centre for Reproductive Medicine has played a pioneering role in the development and enhancement of reproductive techniques. For decades the Centre has been a major player on the international scene in its discipline.
"We are very excited and proud to win this award. Research is exciting but to win such an award brings even greater motivation to continue our work. Appreciation from our team and staff is so important but to get appreciation from a company like Ferring is really something." Dr Christophe Blockeel.
University Medical Center Utrecht, The Netherlands.
Research title: Assessment of oocyte quality by embryo aneuploidy rates and cumulus cell gene expression: effect of late follicular phase hCG administration.
Dr Esther Baart, principal applicant of the second winning institution also awarded 50,000 Euros is a Clinical Embryologist and researcher in the Department of Reproduction and Gynaecology, University Medical Centre Utrecht (UMC Utrecht). UMC Utrecht is one of the largest public healthcare institutions in The Netherlands and is renowned for the quantity and quality of their international scientific publications. This high position can be attributed to a number of both clinical and pre-clinical research groups and national and international collaboration is an important positive factor in this.
"Receiving the award gives an enormous b
|SOURCE Ferring Pharmaceuticals|
Copyright©2008 PR Newswire.
All rights reserved